scorecardresearch
Thursday, July 31, 2025
TopicCovid-19 vaccine

Topic: Covid-19 vaccine

Hyderabad’s CCMB to set up exclusive lab to develop RNA tech for use in Covid vaccines

Development comes amid talks the Centre for Cellular and Molecular Biology is holding with Moderna to manufacture the American biotech firm’s vaccine in India.

Covid vaccine Sputnik V has 91.6% efficacy, Lancet report says. Makers expecting India nod

Kirill Dmitriev, CEO of Russian Direct Investment Fund that makes Sputnik V, also says majority of vaccine doses will be manufactured in India.

Why it takes 2 shots to make mRNA vaccines do the trick

This is what happens to the human body between the first and second dose of an mRNA vaccine.

EU’s U-turn on Covid vaccine exports to UK, and the ‘gutless QAnon party’

The best cartoons of the week, chosen by the editors at ThePrint.

CSIR in talks to bring Moderna’s Covid vaccine to India, says its chief Shekhar Mande

Mande says current talks are scientific, and once CSIR’s Hyderabad-based CCMB understands Moderna’s mRNA technology, it can produce the vaccine ‘within weeks’.

Indian vaccine makers excellent example for lower income countries, Gavi deputy CEO says

Anuradha Gupta, deputy CEO of Gavi, the global vaccine alliance, tells ThePrint India is crucial for the global Covid vaccine response.

Unlike rest of the world, India has plenty of Covid vaccines but few takers

As of 25 January 2021, only about 56% of people eligible to get the shot have stepped forward in a nation with the world’s second-worst Covid-19 outbreak.

Indians must have no confusion about how we reached impressive Covid herd immunity

India’s masses didn’t have the luxury to ‘work from home’ and follow social distancing, but they might have silently built India’s herd immunity.

Adverse events reported in just 0.08% of 15 lakh Covid vaccinations in first week

Most AEFIs reported were minor, such as fever or pain at the injection site. Only 11 people needed to be hospitalised, across six states and capital Delhi.

Why a ‘mucosal’ Covid vaccine has a better shot at ending the pandemic

Novel coronavirus is a pathogen of a ‘mucosal’ organ, different to ‘systemic’ organs. Current vaccines are systemic, and can only reduce disease severity.

On Camera

Meghnad Desai was a man of many passions. Marxian economics, politics to Bollywood

Meghnad’s interest went much beyond economics and politics. This is reflected in his writing, particularly after his retirement as a full-time LSE professor in 2003.

Govt’s earlier FDI limit of 74% in insurance sector has remained underutilised, Parliament told

In the latest budget, the FDI limit was increased to 100 percent, but most foreign companies are not buying such large stakes in the Indian insurance sector.

India to get last of Spain-built C-295 next month, focus now on 1st India-made aircraft

New Delhi: The last of the C-295 transport aircraft that is replacing the ageing Avro fleet of the Indian Air Force (IAF) will be...

Modi’s Bharat vs Indira’s India: 11-yr report card of politics, diplomacy, economy, nationalism

As Narendra Modi becomes India’s second-longest consecutively serving Prime Minister, we look at how he compares with Indira Gandhi across four key dimensions.